* Rapid Micro Biosystems Inc RPID.OQ RPID.O is expected
to show a fall in quarterly revenue when it reports results on
November 10.
* The Lowell Massachusetts-based company is expected to
report a
42.5% decrease in revenue to $3.967 million from $6.9 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Rapid Micro
Biosystems
Inc is for a loss of 37 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Rapid Micro
Biosystems Inc is $9, above its last closing price of $2.69.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.33 -0.32 -0.31 Beat 2.4
Mar. 31 2022 -0.34 -0.33 -0.35 Missed -4.5
Dec. 31 2021 -0.24 -0.28 -0.35 Missed -25
Sep. 30 2021 -0.38 -0.38 -0.63 Missed -67.3
Jun. -0.40 -0.40 -20.01 Missed -4,902
30 2021 .5
This summary was machine generated November 8 at 17:23 GMT. All
figures in US dollars unless otherwise stated